Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2111448 Target Snapshot

CDK6/cyclin D3 · PROTEIN COMPLEX · Homo sapiens

1,051Compounds
198Assays
6Approved Drugs
907.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P30281. Use UniProt P30281 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P30281 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats CDK6/cyclin D3 as ChEMBL target CHEMBL2111448, mapped to UniProt P30281. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
CDK6/cyclin D3
PROTEIN COMPLEX · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL2111448
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P30281
G1/S-specific cyclin-D3
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether CDK6/cyclin D3 is the right protein anchor across sources, using UniProt P30281 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelG1/S-specific cyclin-D3
UniProt AccessionP30281
Component TypeProtein
Sequence Length292 aa

G1/S-specific cyclin-D3

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as CDK6/cyclin D3, mapped to UniProt P30281. ChEMBL maps the protein component as G1/S-specific cyclin-D3. Sequence length is 292 aa.

Mapped IDP30281
Review nameCDK6/cyclin D3
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

6
Approved
2
Phase III
6
Phase II
4
Phase I
Assay Mix

Activity Type Distribution

IC50515.0
KI391.0
KD1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5970111 9.7 IC50 0.2 Preclinical
CHEMBL4285830 9.41 IC50 0.39 Preclinical
CHEMBL5739950 9.4 IC50 0.4 Preclinical
CHEMBL5876670 9.4 Ki 0.4 Preclinical
CHEMBL4279832 9.31 IC50 0.49 Preclinical
CHEMBL4277900 9.14 IC50 0.73 Clinical
CHEMBL5749795 9.05 Ki 0.9 Preclinical
CHEMBL5903827 9.05 IC50 0.9 Preclinical
CHEMBL4281514 9.0 IC50 1.0 Preclinical
CHEMBL5816600 9.0 Ki 1.0 Preclinical
Distribution

pChEMBL Value Distribution

30
5.0
25
5.5
38
6.0
76
6.5
148
7.0
176
7.5
168
8.0
68
8.5
21
9.0
1
9.5
pChEMBL
Approved Drugs

Approved Drugs

TRILACICLIB
CHEMBL3894860
Approved 2021
ABEMACICLIB
CHEMBL3301610
Approved 2017
RIBOCICLIB
CHEMBL3545110
Approved 2017
PALBOCICLIB
CHEMBL189963
Approved 2015
Assay Landscape

Assay Landscape

198
Total Assays
565
Tested Compounds
1
Assay Types
Binding — 198 assays, 565 compounds
BAO Format Assays Compounds Avg pChEMBL
protein complex format 161 436 7.5
cell-based format 22 58 6.8
assay format 12 66 7.5
single protein format 3 5 5.8

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine